BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25815756)

  • 1. Restless legs syndrome associated with the combined use of duloxetine plus paroxetine.
    Nikolaou KN; Michopoulos I; Douzenis A; Papazahos C; Papageorgiou C; Gournellis R
    J Clin Psychopharmacol; 2015 Jun; 35(3):345-6. PubMed ID: 25815756
    [No Abstract]   [Full Text] [Related]  

  • 2. Restless legs syndrome following the combined use of quetiapine and paroxetine.
    Chou KJ; Chen PY; Huang MC
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):1139-40. PubMed ID: 20470847
    [No Abstract]   [Full Text] [Related]  

  • 3. Fluoxetine-mirtazapine interaction may induce restless legs syndrome: report of 3 cases from a clinical trial.
    Prospero-Garcia KA; Torres-Ruiz A; Ramirez-Bermudez J; Velazquez-Moctezuma J; Arana-Lechuga Y; Teran-Perez G
    J Clin Psychiatry; 2006 Nov; 67(11):1820. PubMed ID: 17196069
    [No Abstract]   [Full Text] [Related]  

  • 4. Suspected duloxetine-induced restless legs syndrome phenotypic variant: a case report.
    Shao Y; Chen Y; Wang S; Li C; Sun H; Sun X
    BMC Psychiatry; 2024 May; 24(1):349. PubMed ID: 38730422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duloxetine-related galactorrhea and restless legs syndrome: a case report.
    Belli H; Akbudak M; Ural C
    Psychiatr Danub; 2013 Sep; 25(3):266-7. PubMed ID: 24048395
    [No Abstract]   [Full Text] [Related]  

  • 6. Restless legs syndrome and paroxetine.
    Sanz-Fuentenebro FJ; Huidobro A; Tejadas-Rivas A
    Acta Psychiatr Scand; 1996 Dec; 94(6):482-4. PubMed ID: 9021005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and duration of antidepressant-induced nausea: duloxetine compared with paroxetine and fluoxetine.
    Greist J; McNamara RK; Mallinckrodt CH; Rayamajhi JN; Raskin J
    Clin Ther; 2004 Sep; 26(9):1446-55. PubMed ID: 15531007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Once-daily duloxetine 60 mg in the treatment of major depressive disorder: multicenter, double-blind, randomized, paroxetine-controlled, non-inferiority trial in China, Korea, Taiwan and Brazil.
    Lee P; Shu L; Xu X; Wang CY; Lee MS; Liu CY; Hong JP; Ruschel S; Raskin J; Colman SA; Harrison GA
    Psychiatry Clin Neurosci; 2007 Jun; 61(3):295-307. PubMed ID: 17472599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined antidepressant treatment: a risk factor for switching in bipolar patients.
    Gabbay V; O'Dowd MA; Asnis GM
    J Clin Psychiatry; 2002 Apr; 63(4):367; author reply 367-8. PubMed ID: 12000212
    [No Abstract]   [Full Text] [Related]  

  • 10. A case of retrobulbar optic neuritis caused by duloxetine.
    Bicer T; Kosker M; Celikay O; Gurdal C
    Cutan Ocul Toxicol; 2016 Sep; 35(3):251-3. PubMed ID: 26362493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restless legs syndrome induced by mirtazapine.
    Ağargün MY; Kara H; Ozbek H; Tombul T; Ozer OA
    J Clin Psychiatry; 2002 Dec; 63(12):1179. PubMed ID: 12530413
    [No Abstract]   [Full Text] [Related]  

  • 12. A case of paroxetine-induced akathisia.
    Olivera AA
    Biol Psychiatry; 1996 May; 39(10):910. PubMed ID: 8860197
    [No Abstract]   [Full Text] [Related]  

  • 13. Comments on "An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606 in patients with treatment-refractory major depressive disorder".
    Hashimoto K
    J Clin Psychopharmacol; 2009 Aug; 29(4):411-2; author reply 412. PubMed ID: 19593196
    [No Abstract]   [Full Text] [Related]  

  • 14. Restless Legs Syndrome Related to Vortioxetine: A Case Report.
    Romigi A; Vitrani G; Caccamo M; Centonze D
    J Clin Psychopharmacol; 2019; 39(5):514-516. PubMed ID: 31433340
    [No Abstract]   [Full Text] [Related]  

  • 15. [Restless legs syndrome and depression].
    Rasmussen J; Videbech P
    Ugeskr Laeger; 2011 Aug; 173(35):2113-7. PubMed ID: 21884661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dangers of Rapid Dosing: A Case of Dose-Dependent Drug-Induced Liver Injury From Duloxetine.
    Kassam AS; Cunningham EA; Musco SE
    Prim Care Companion CNS Disord; 2019 Mar; 21(2):. PubMed ID: 30916900
    [No Abstract]   [Full Text] [Related]  

  • 17. Atypical Stevens-Johnson syndrome in an adolescent treated with duloxetine.
    Strawn JR; Whitsel R; Nandagopal JJ; Delbello MP
    J Child Adolesc Psychopharmacol; 2011 Feb; 21(1):91-2. PubMed ID: 21309700
    [No Abstract]   [Full Text] [Related]  

  • 18. Delirium associated with concomitant use of duloxetine and bupropion in an elderly patient.
    Ma SP; Tsai CJ; Chang CC; Hsu WY
    Psychogeriatrics; 2017 Mar; 17(2):130-132. PubMed ID: 27046219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute and longer-term safety results from a pooled analysis of duloxetine studies for the treatment of children and adolescents with major depressive disorder.
    Emslie GJ; Wells TG; Prakash A; Zhang Q; Pangallo BA; Bangs ME; March JS
    J Child Adolesc Psychopharmacol; 2015 May; 25(4):293-305. PubMed ID: 25978741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hiccups With Dose Titration of Aripiprazole.
    Mathews M; Mathews N; Menon N; Ahmad R; Papa-Molter A
    Prim Care Companion CNS Disord; 2018 Nov; 20(6):. PubMed ID: 30476376
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.